Skip to main content Skip to footer

Patients Investors

Tablo
Providers
About Us
Stories
More
- Careers
- Contact Us
- Events
- Resources
- Press Highlights
- FAQ

Tablo
Providers
About Us
Stories
More
- Careers
- Contact Us
- Events
- Resources
- Press Highlights
- FAQ

Search site

Search

Amelia Merrill

VP, People Operations and Culture

Atizaz Ahsan·December 12, 2019·0 comments

Amelia-Merrill

Amelia Merrill

VP, People Operations and Culture

—

Atizaz Ahsan

Related posts

Leslie Trigg
Chair and CEO
December 1, 2019
Michael Aragon
Chief Medical Officer
December 3, 2019
John Brottem
General Counsel
December 4, 2019

Jim Mazzola

VP, Corporate Communication and Investor Relations

Isaac Stockwell

VP, Information Technology

INDICATIONS FOR USE:

The Tablo^® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.

2214-v2

Stay connected

Tablo

Clinical evidence EMR Connect Services

Patients

Kidney health 101 Request more info Why home dialysis

Healthcare providers

Administrators Nephrologists Nurses Skilled Nursing Facilities Request a demo

Resources

Customer resources Events & news FAQ Press highlights Stories

About

Careers Contact Investors

Safety & Legal

Consumer Health Data Privacy Cookie policy Do not sell/share my personal info Important Safety Information Patents Privacy policy
(Updated 10/31/25)Terms of Use

© 2025 Outset Medical, Inc. All rights reserved. Outset, Tablo, TabloCart, MyTablo, TabloHub, and Better Begins Now are trademarks of our company.